Attention:

As we update our core systems, key features of the website including ordering and real-time price and availability, may be unavailable from 8 PM CST on Friday evening, September 20th until 9 AM CST on Saturday morning, September 21st.

Please note that you will still have telephone and email access to our local offices during this period.

We apologize for any inconvenience this may cause.

Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

SDS

Search for SDS (Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Academic Research Programs

Designed to meet all your research needs: Stocking Centers, New Lab Start-Up, Core Programs and access to special offers

Contact Us

Customer Service: 800-565-1400

Email Subscription Center

To receive the information that is relevant to your work, explore our subscription center and set your preferences

Corporate Responsibility

Learn more about our commitment to people, green chemistry and the environment

About Us

Our life science business features a portfolio of more than 300,000 products enabling scientific discovery.

Advanced Structure Search

Copy and paste, advanced query features, instant structure to name generation, element analysis and more

News & Information

Burlington & Cambridge, Massachusetts - August 6, 2019 MilliporeSigma Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab

MilliporeSigma has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving.

Read More
Shanghai, China - July 24, 2019 MilliporeSigma to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics

MilliporeSigma today announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on the development and manufacture of biologics for the treatment of solid tumors.

Read More
Burlington & Cambridge, Massachusetts - July 18, 2019 MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation

MilliporeSigma and the Broad Institute of MIT and Harvard today announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product development.

Read More